Search for a clinical trial
Other search option(s)
10 Result(s)
Recruiting trial
= 
; Ongoing trial
= 
; Funded by an IRDiRC member = 
; Member of a ERN = 
National clinical trial(s)
AUSTRIA
WIEN
ADDRESS: NOT PROVIDED - AT
TALAPRO-1: A phase 2, open-label, response rate study of talazoparib in men with DNA repair defects metastatic castration-resistant prostate cancer who previously received taxane-based chemotherapy and progressed on at least 1 novel hormonal agent (enzalutamide and/or abiraterone acetate/prednisone) - AT
Institution: Information not provided - AT
BELGIUM
VLAAMS BRABANT
LEUVEN
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study - BE
UZ Leuven - Campus Gasthuisberg
Laboratory of Pediatric Immunology
GERMANY
Berlin
ADDRESS: NOT PROVIDED - DE
Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Institution: Information not provided - DE
GERMANY
Hessen
FRANKFURT AM MAIN
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study -DE-
Universitätsklinikum Frankfurt
Schwerpunkt Allergologie, Pneumologie und Mukoviszidose
SPAIN
Madrid
MADRID
OLE-IEDAT: Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 Study - ES
Hospital Universitario La Paz
Servicio de Neurología
SPAIN
Madrid
MADRID
Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A multinational, multicenter, open-label, rater-blinded Phase II study - ES
Hospital Universitario La Paz
Servicio de Neurología infantil
ITALY
LAZIO
ROMA
Effect of riluzole as a symptomatic approach in patients with chronic cerebellar ataxia
A.O. S. Andrea
U.O.C. di Neurologia
NORWAY
Østlandet
SIGGERUD
Forebygging av mentale vansker blant søsken til barn med nevroutviklingsforstyrrelser
Frambu kompetansesenter for sjeldne diagnoser
UNITED STATES
California
WESTLAKE VILLAGE
Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric Subjects with Primary Immunodeficiency Diseases-GB
Baxalta US, Inc.
Multinational clinical trial(s)
ITALY
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT